Diploma PLC (LON:DPLM) Insider Katie Bickerstaffe Purchases 44 Shares

Diploma PLC (LON:DPLM) insider Katie Bickerstaffe bought 44 shares of the stock in a transaction on Wednesday, May 21st. The shares were acquired at an average cost of GBX 4,867 ($65.33) per share, for a total transaction of £2,141.48 ($2,874.47).

Katie Bickerstaffe also recently made the following trade(s):

• On Tuesday, May 20th, Katie Bickerstaffe bought 39 shares of Diploma stock. The shares were acquired at an average cost of GBX 4,981 ($66.86) per share, for a total transaction of £1,942.59 ($2,607.50).
• On Tuesday, May 20th, Katie Bickerstaffe bought 13 shares of Diploma stock. The shares were acquired at an average cost of GBX 4,982 ($66.87) per share, for a total transaction of £647.66 ($869.34).

Diploma Trading Down 2.3%

Diploma stock opened at GBX 4,764.09 ($63.95) on Friday. The company has a debt-to-equity ratio of 62.17, a current ratio of 2.17 and a quick ratio of 0.80. The company has a market capitalization of £6.35 billion, a price-to-earnings ratio of 54.76, a PEG ratio of 2.82 and a beta of 0.75. Diploma PLC has a one year low of GBX 3,532 ($47.41) and a one year high of GBX 5,025 ($67.45). The company’s fifty day moving average price is GBX 3,983.88 and its two-hundred day moving average price is GBX 4,260.86.

Diploma (LON:DPLM) last issued its quarterly earnings results on Wednesday, May 21st. The company reported GBX 80.20 ($1.08) earnings per share (EPS) for the quarter. Diploma had a return on equity of 13.18% and a net margin of 9.25%. On average, analysts forecast that Diploma PLC will post 163.7995512 earnings per share for the current fiscal year.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.